Bafna Pharmaceuticals Ltd. Share Price & Stock Analysis

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Key Metrics

Current Price	₹194.68
Market Cap	₹371 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Pharmaceutical Products
P/E Ratio	33.4
Return on Equity	12.27%
52-Week Range	₹74.50 – ₹213.36
Beta (1Y)	0.18

Business Segments

1. Manufacturing of Pharmaceuticals Formations,-100%

Peer Companies

• Abbott India Ltd.
• Ajanta Pharma Limited
• Astrazeneca Pharma India Ltd.
• Pfizer Ltd.
• Eris Lifesciences Ltd
• Caplin Point Laboratories Ltdte
• Marksans Pharma Ltd.
• Strides Pharma Science Limited (Star)

Frequently Asked Questions

What is the current share price of Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. is trading at ₹194.68, with a market capitalisation of ₹371 Cr.

Which sector does Bafna Pharmaceuticals Ltd. belong to?

Bafna Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).

What are the key financial ratios of Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. has a P/E of 33.4 and a return on equity of 12.27%.